Fullscript (Canada) has announced it has completed the acquisition of Emerson Ecologics (Manchester, NH), a long-standing player in the integrative health care industry. This transaction nearly doubles the annual revenue of Fullscript and doubles the number of integrative medicine patients and practitioners Fullscript supports to more than 70,000 health care professionals and more than 5 million patients.
“This acquisition is a giant step toward bringing integrative medicine into the mainstream. It provides Fullscript with the scale and technology to arm practitioners with the tools they need to practice health promoting medicine,” said Kyle Braatz, CEO, Fullscript. “Both Fullscript and Emerson Ecologics have always been committed to supporting practitioners in the delivery of care, and we know that as one entity we can create tremendous value and growth for the entire ecosystem, from partners to practitioners to patients; we are going to help a lot of people get better.”
The Fullscript platform now provides access to additional key professional grade supplements and wellness brands, diagnostic testing and an expanded distribution network to enhance the practitioner and patient experience. In addition, Fullscript will continue its extensive investment in treatment adherence, personalized care, and cutting-edge clinical research to support the advancement and spread of integrative medicine, which grew at a 25 percent CAGR between 2012 and 2020.
“With the continued rise of chronic, often reversible diseases, the conventional model of patient care is ripe for disruption, and Fullscript is helping drive that change,” added Dr. Jeff Gladd, chief medical officer, Fullscript. “Integrative medicine, a philosophy of care built on a foundation of health promotion rather than simply the management of disease, allows providers to partner with their patients and guide individual health journeys founded on the core principles of health: nutrition, movement, and mindfulness.”
For more information, visit https://fullscript.com/.